Tenderskhoj
Germany
- Healthcare & Medical Medical
LOCATION SUMMARY DEADLINE
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Ixekizumab, Atc L04ac13 (obo) For The Period July 1st, 2024 June 30th, 2026
05 May 2026
Germany Coverage Check According To § 44 Para. 1 Set 2 Kwg I. V. M. § 3 Para. 1 Sentence 3 Pfandbg At Hamburg Commercial Bank Ag
06 Jun 2024
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Dornase Alfa, Atc R05cb13 (obo) For The Period July 1st, 2024 June 30th, 2026
05 May 2026
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Etravirin, Atc J05ag04 (obo) For The Period July 1st, 2024 - June 30th, 2026
05 May 2026
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Piribedil, Atc N04bc08 (obo) For The Period July 1st, 2024 - June 30th, 2025 (one Year Extension Option)
05 May 2026
Germany Drug Discount Agreements In Accordance With Section 130a Para. 8 Sgb V In The Context Of Open House Procedures
06 Mar 2026
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Etravirin, Atc J05ag04 (obo) For The Period July 1st, 2024 June 30th, 2026
05 May 2026
Germany Prolene Bl. Monofil 75cm 2xc1 Usp 4-0/36
11 Jun 2024
Germany Prolene Bl. Monofil 75cm 2xc1 Usp 4-0/36
11 Jun 2024
Germany Prolene Bl. Monofil 75cm 2xc1 Usp 4-0/36
11 Jun 2024